Paper20100871
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
Lutgens E and 19 others. J Exp Med, 2010. Cited by 229 papers, by iCite.
Cite this record
ConductScience Library. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. Papers, record 20100871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20100871
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| CD40 Antigens | Major topic |
| CD40 Ligand | Major topic |
| Signal Transduction | Major topic |
| TNF Receptor-Associated Factor 6 | Major topic |
| Animals | |
| Anti-Inflammatory Agents | |
| Apolipoproteins E | |
| Disease Progression | |
| Inflammation | |
| Inflammation Mediators | |
| Leukocytes | |
| Mice | |
| TNF Receptor-Associated Factor 2 | |
| TNF Receptor-Associated Factor 3 | |
| TNF Receptor-Associated Factor 5 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0802651 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19122657 | Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. | Nat Med | 2009 | https://conductscience.org/library/papers/19122657 | PubMed |
| 2 | 9990007 | Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9990007 | PubMed |
| 3 | 11875495 | CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism. | Nat Med | 2002 | https://conductscience.org/library/papers/11875495 | PubMed |
| 4 | 18825131 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18825131 | PubMed |
| 5 | 8637903 | CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8637903 | PubMed |
| 6 | 16462800 | Natural regulatory T cells control the development of atherosclerosis in mice. | Nat Med | 2006 | https://conductscience.org/library/papers/16462800 | PubMed |
| 7 | 11913066 | Mouse and human dendritic cell subtypes. | Nat Rev Immunol | 2002 | https://conductscience.org/library/papers/11913066 | PubMed |
| 8 | 10807742 | Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. | Arterioscler Thromb Vasc Biol | 2000 | https://conductscience.org/library/papers/10807742 | PubMed |
| 9 | 19616449 | The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. | Semin Immunol | 2009 | https://conductscience.org/library/papers/19616449 | PubMed |
| 10 | 11967542 | The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. | Nat Immunol | 2002 | https://conductscience.org/library/papers/11967542 | PubMed |
| 11 | 17200718 | Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200718 | PubMed |
| 12 | 15634933 | TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. | J Immunol | 2005 | https://conductscience.org/library/papers/15634933 | PubMed |
| 13 | 19132917 | Blood monocytes: development, heterogeneity, and relationship with dendritic cells. | Annu Rev Immunol | 2009 | https://conductscience.org/library/papers/19132917 | PubMed |
| 14 | 17332487 | TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. | Arterioscler Thromb Vasc Biol | 2007 | https://conductscience.org/library/papers/17332487 | PubMed |
| 15 | 10861013 | Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10861013 | PubMed |
| 16 | 17633015 | Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. | Adv Exp Med Biol | 2007 | https://conductscience.org/library/papers/17633015 | PubMed |
| 17 | 16778830 | The immune response in atherosclerosis: a double-edged sword. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/16778830 | PubMed |
| 18 | 18195092 | The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. | Blood | 2008 | https://conductscience.org/library/papers/18195092 | PubMed |
| 19 | 19696407 | Macrophage diversity and polarization in atherosclerosis: a question of balance. | Arterioscler Thromb Vasc Biol | 2009 | https://conductscience.org/library/papers/19696407 | PubMed |
| 20 | 17200719 | Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17200719 | PubMed |
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 229 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368990 | Inflammation at the Crossroads: Familial Mediterranean Fever and Cardiovascular Risk. | Mediterr J Rheumatol | 2026 | https://conductscience.org/library/papers/42368990 | PubMed |
| 42069568 | Human birth tissue products for pathological pain: mechanisms, evidence, and translational outlook. | J Transl Med | 2026 | https://conductscience.org/library/papers/42069568 | PubMed |
| 41268556 | TNF superfamily molecules in atherosclerosis: mechanistic insights and therapeutic translation. | Front Immunol | 2025 | https://conductscience.org/library/papers/41268556 | PubMed |
| 41260511 | CD40 drives tumor growth in non-small cell lung cancer via non-canonical immune-independent mechanisms. | Cancer Lett | 2026 | https://conductscience.org/library/papers/41260511 | PubMed |
| 41039608 | Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation. | Genome Med | 2025 | https://conductscience.org/library/papers/41039608 | PubMed |
| 41017678 | Immune dysregulation and gut microbiota: Connection to health and disease development. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41017678 | PubMed |
| 40595262 | Integrative bioinformatics frameworks for abdominal aortic aneurysm using GWAS meta-analysis, biological network construction, and structural modeling. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595262 | PubMed |
| 40027444 | Structural bioinformatics for rational drug design. | Res Pract Thromb Haemost | 2025 | https://conductscience.org/library/papers/40027444 | PubMed |
| 39899926 | CD40-TRAF6 inhibition suppresses cardiovascular inflammation, oxidative stress and functional complications in a mouse model of arterial hypertension. | Redox Biol | 2025 | https://conductscience.org/library/papers/39899926 | PubMed |
| 39817455 | T cells in cardiac health and disease. | J Clin Invest | 2025 | https://conductscience.org/library/papers/39817455 | PubMed |
| 39816684 | Macrophage-based pathogenesis and theranostics of vulnerable plaques. | Theranostics | 2025 | https://conductscience.org/library/papers/39816684 | PubMed |
| 39680334 | Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities. | Pharmacol Rep | 2025 | https://conductscience.org/library/papers/39680334 | PubMed |
| 39364866 | Non-rodent Models of Atherosclerosis: Repurposing of Existing Drugs and Search for Novel Treatment Strategies. | Curr Cardiol Rev | 2025 | https://conductscience.org/library/papers/39364866 | PubMed |
| 39070270 | Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis? | JACC Basic Transl Sci | 2024 | https://conductscience.org/library/papers/39070270 | PubMed |
| 38979792 | Peritoneal Dialysis Aggravates and Accelerates Atherosclerosis in Uremic ApoE-/- Mice. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38979792 | PubMed |
| 38696700 | Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/38696700 | PubMed |
| 38554187 | Role of inflammatory signaling pathways involving the CD40-CD40L-TRAF cascade in diabetes and hypertension-insights from animal and human studies. | Basic Res Cardiol | 2024 | https://conductscience.org/library/papers/38554187 | PubMed |
| 38106460 | Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy. | Curr Res Struct Biol | 2023 | https://conductscience.org/library/papers/38106460 | PubMed |
| 37681883 | T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease. | Cells | 2023 | https://conductscience.org/library/papers/37681883 | PubMed |
| 37215541 | Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/37215541 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| CD40 | 958 | PubTator's text mining | https://conductscience.org/library/genes/958 | NCBI Gene |
| CD40LG | 959 | PubTator's text mining | https://conductscience.org/library/genes/959 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
| TRAF2 | 7186 | PubTator's text mining | https://conductscience.org/library/genes/7186 | NCBI Gene |
| TRAF3 | 7187 | PubTator's text mining | https://conductscience.org/library/genes/7187 | NCBI Gene |
| TRAF5 | 7188 | PubTator's text mining | https://conductscience.org/library/genes/7188 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20100871
GET https://conductscience.org/api/papers/v1/20100871/references?page=2